previous compound ID: 2081 next compound
InChIKey: SGZRQMALQBXAIQ-UHFFFAOYSA-N
SMILES: CC(CC1=CC=C(C=C1)O)NCC(C2=CC(=CC(=C2)O)O)O.Br

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"DY Thomas" "B Kus" "GW Carlile" "J Liao" "JW Hanrahan" "J Goepp" "SD Macknight" "D Rotin" "E Matthes" "R Robert"

chemical graph of compound 2081





CID is 16037
synonyms found at PubChem are:
TH 1165A, EINECS 217-742-8, 5-(1-Hydroxy-2-((2-(4-hydroxyphenyl)-1-methylethyl)amino)ethyl)resorcinol hydrobromide, 1-(3,5-Dihydroxy-phenyl)-2-((1-(4-hydroxybenzyl)ethyl)amino)-ethanol hydrobromide, AC1Q1RJP, Benzyl alcohol, 3,5-dihydroxy-alpha-(((p-hydroxy-alpha-methylphenethyl)amino)methyl)-, hydrobromide, AC1L274R, AN-17358, LS-42859, [2-(3,5-dihydroxyphenyl)-2-hydroxyethyl]-[1-(4-hydroxyphenyl)propan-2-yl]azanium bromide, 1,3-Benzenediol, 5-(1-hydroxy-2-((2-(4-hydroxyphenyl)-1-methylethyl)amino)ethyl)-, HBr, [2-(3,5-dihydroxyphenyl)-2-hydroxy-ethyl]-[2-(4-hydroxyphenyl)-1-methyl-ethyl]ammonium bromide, 5-(1-hydroxy-2-{[1-(4-hydroxyphenyl)propan-2-yl]amino}ethyl)benzene-1,3-diol hydrobromide(1:1), Fenoterol hydrobromide, 1944-12-3, fenoterol HBr, Fenoterol (hydrobromide), Fenoterol bromide, Phenoterol hydrobromide, Partusisten, CHEBI:31601, Berotec (TN), DSSTox_CID_25419, DSSTox_RID_80867, DSSTox_GSID_45419, Fenoterol hydrobromide (JAN), Fenoterol hydrobromide [JAN], CHEMBL537445, 2-(3,5-Dihydroxyphenyl)-2-hydroxy-2'-(4-hydroxyphenyl)-1'-methyldiethylamine hydrobromide, CAS-1944-12-3, SR-01000075873, Fenoterol-d6, 5-(1-hydroxy-2-(1-(4-hydroxyphenyl)propan-2-ylamino)ethyl)benzene-1,3-diol hydrobromide, 5-[1-hydroxy-2-[1-(4-hydroxyphenyl)propan-2-ylamino]ethyl]benzene-1,3-diol hydrobromide, Prestwick_667, AC1NWASK, NCGC00016721-01, MLS001056741, ARONIS24570, SCHEMBL121549, SPECTRUM1501007, DTXSID5045419, CTK8F9746, HY-B0976A, BBC/743, MolPort-003-666-344, REGID_for_CID_5702161, SGZRQMALQBXAIQ-UHFFFAOYSA-N, HMS1568J06, HMS1921B11, Pharmakon1600-01501007, 13392-18-2 (Parent), BCP28959, ZX-AS004943, Tox21_110581, Tox21_500544, BG0190, CCG-38987, NSC757811, AKOS015909691, Tox21_110581_1, API0002690, CS-5285, KS-5090, LP00544, NSC-757811, NCGC00015430-06, NCGC00093932-01, NCGC00093932-02, NCGC00093932-03, NCGC00093932-04, NCGC00261229-01, S314, SMR000326705, ACM1286129041, EU-0100544, FT-0668501, ST51015001, VU0243157-4, D01428, F 1016, C-54957, J-012593, SR-01000075873-1, SR-01000075873-6, I14-31833, Fenoterol hydrobromide, European Pharmacopoeia (EP) Reference Standard, 2-[3,5-Dihydroxyphenyl]-2- hydroxy-2 -[4-hydroxyphenyl]- 1 -methyldiethylamine, 5-(1-hydroxy-2-{[1-(4-hydroxyphenyl)propan-2-yl]amino}ethyl)benzene-1,3-diol hydrobromide, 5-(1-hydroxy-2-{[2-(4-hydroxyphenyl)-isopropyl]amino}ethyl)benzene-1,3-diol, b romide, Fenoterol for peak identification, European Pharmacopoeia (EP) Reference Standard, 1,3-Benzenediol, 5-(1-hydroxy-2-((2-(4-hydroxyphenyl)-1-methylethyl)amino)ethyl)-, HBr (9CI), 2-(3,5-Dihydroxyphenyl)-2-hydroxy-2 inverted exclamation marka-(4-hydroxyphenyl)-1 inverted exclamation marka-methyldiethylamine hydrobromide